{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:14:52Z","timestamp":1707524092440},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8,27]]},"DOI":"10.7759\/cureus.10078","type":"journal-article","created":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T18:02:48Z","timestamp":1598551368000},"source":"Crossref","is-referenced-by-count":4,"title":["Sodium-Glucose Linked Transporter Inhibitors as a Cause of Euglycemic Diabetic Ketoacidosis on a Background of Starvation"],"prefix":"10.7759","author":[{"given":"Abubakar","family":"Tauseef","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Sohaib","family":"Asghar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Zafar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noman","family":"Lateef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Thirumalareddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00106","article-title":"Review of evidence for adult diabetic ketoacidosis management protocols","volume":"8","author":"Tran TT","year":"2017","unstructured":"Tran TT, Pease A, Wood AJ, Zajac JD, M\u00e5rtensson J, Bellomo R, Ekinci EI. Review of evidence for adult diabetic ketoacidosis management protocols. Front Endocrinol. 2017, 8:106. 10.3389\/fendo.2017.00106","journal-title":"Front Endocrinol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12401","article-title":"Euglycemic diabetic ketoacidosis induced by SGLT2 inhibitors: possible mechanism and contributing factors","volume":"7","author":"Ogawa W","year":"2016","unstructured":"Ogawa W, Sakaguchi K. Euglycemic diabetic ketoacidosis induced by SGLT2 inhibitors: possible mechanism and contributing factors. J Diabetes Investig. 2016, 7:135-138. 10.1111\/jdi.12401","journal-title":"J Diabetes Investig"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2174\/1573399812666160421121307","article-title":"Euglycemic diabetic ketoacidosis: a review","volume":"13","author":"Modi A","year":"2017","unstructured":"Modi A, Agrawal A, Morgan F. Euglycemic diabetic ketoacidosis: a review. Curr Diabetes Rev. 2017, 13:315-321. 10.2174\/1573399812666160421121307","journal-title":"Curr Diabetes Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.5811\/cpcem.2017.12.36213","article-title":"Sodium-glucose cotransporter-2 induced diabetic ketoacidosis with minimal hyperglycemia","volume":"2","author":"Gammons DT","year":"2018","unstructured":"Gammons DT, Counselman FL. Sodium-glucose cotransporter-2 induced diabetic ketoacidosis with minimal hyperglycemia. Clin Pract Cases Emerg Med. 2018, 2:47-50. 10.5811\/cpcem.2017.12.36213","journal-title":"Clin Pract Cases Emerg Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2337\/diaclin.33.1.37","article-title":"Rare presentations of ketoacidosis: diabetic ketoalkalosis and ketoacidosis secondary to fasting and muscular dystrophy","volume":"33","author":"Svart MV","year":"2015","unstructured":"Svart MV, Voss TS, Bayat M, Madsen LR, Andersen LT, Poulsen PL, M\u00f8ller N. Rare presentations of ketoacidosis: diabetic ketoalkalosis and ketoacidosis secondary to fasting and muscular dystrophy. Clin Diabetes. 2015, 33:37-39. 10.2337\/diaclin.33.1.37","journal-title":"Clin Diabetes"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.917226","article-title":"Starvation ketoacidosis due to the ketogenic diet and prolonged fasting: a possibly dangerous diet trend","volume":"20","author":"Blanco JC","year":"2019","unstructured":"Blanco JC, Khatri A, Kifayat A, Cho R, Aronow WS. Starvation ketoacidosis due to the ketogenic diet and prolonged fasting: a possibly dangerous diet trend. Am J Case Rep. 2019, 20:1728-1731. 10.12659\/AJCR.917226","journal-title":"Am J Case Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-008-0829-0","article-title":"Starvation-induced true diabetic euglycemic ketoacidosis in severe depression","volume":"24","author":"Joseph F","year":"2009","unstructured":"Joseph F, Anderson L, Goenka N, Vora J. Starvation-induced true diabetic euglycemic ketoacidosis in severe depression. J Gen Intern Med. 2009, 24:129-131. 10.1007\/s11606-008-0829-0","journal-title":"J Gen Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2174\/1573399812666160613113556","article-title":"Empagliflozin for type 2 diabetes mellitus: an overview of phase 3 clinical trials","volume":"13","author":"Levine MJ","year":"2017","unstructured":"Levine MJ. Empagliflozin for type 2 diabetes mellitus: an overview of phase 3 clinical trials. Curr Diabetes Rev. 2017, 13:405-423. 10.2174\/1573399812666160613113556","journal-title":"Curr Diabetes Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2016-215340","article-title":"Euglycaemic diabetic ketoacidosis in a patient with type 2 diabetes started on empagliflozin","volume":"2016","author":"Rashid O","year":"2016","unstructured":"Rashid O, Farooq S, Kiran Z, Islam N. Euglycaemic diabetic ketoacidosis in a patient with type 2 diabetes started on empagliflozin. BMJ Case Rep. 2016, 2016:bcr2016215340. 10.1136\/bcr-2016-215340","journal-title":"BMJ Case Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/ams2.480","article-title":"Euglycemic diabetic ketoacidosis due to a strict low-carbohydrate diet during treatment with sodium-glucose cotransporter 2 inhibitors","volume":"7","author":"Fukuyama Y","year":"2020","unstructured":"Fukuyama Y, Numata K, Yoshino K, Santanda, T, Funakoshi H. Euglycemic diabetic ketoacidosis due to a strict low-carbohydrate diet during treatment with sodium-glucose cotransporter 2 inhibitors. Acute Med Surg. 2020, 7:e480. 10.1002\/ams2.480","journal-title":"Acute Med Surg"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011056","article-title":"Euglycemic diabetic ketoacidosis caused by dapagliflozin: a case report","volume":"97","author":"Chou YM","year":"2018","unstructured":"Chou YM, Seak CJ, Goh ZNL, Seak JCY, Seak CK, Lin CC. Euglycemic diabetic ketoacidosis caused by dapagliflozin: a case report. Medicine. 2018, 97:e11056. 10.1097\/MD.0000000000011056","journal-title":"Medicine"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/1747850","article-title":"Euglycemic diabetic ketoacidosis in the ICU: 3 case reports and review of literature","volume":"2018","author":"Lucero P","year":"2018","unstructured":"Lucero P, Chapela S. Euglycemic diabetic ketoacidosis in the ICU: 3 case reports and review of literature. Case Rep Crit Care. 2018, 2018:1747850. 10.1155\/2018\/1747850","journal-title":"Case Rep Crit Care"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-17-0081","article-title":"Euglycemic diabetic ketoacidosis: a diagnostic and therapeutic dilemma","volume":"2017","author":"Rawla","year":"2017","unstructured":"Rawla, P, Vellipuram AR, Bandaru SS, Pradeep Raj J. Euglycemic diabetic ketoacidosis: a diagnostic and therapeutic dilemma. Endocrinol Diabetes Metab Case Rep. 2017, 2017:17-0081. 10.1530\/EDM-17-0081","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-1380","article-title":"Euglycemic diabetic ketoacidosis: a predictable, detectable, and preventable safety concern with SGLT2 inhibitors","volume":"38","author":"Rosenstock J","year":"2015","unstructured":"Rosenstock J, Ferrannini E. Euglycemic diabetic ketoacidosis: a predictable, detectable, and preventable safety concern with SGLT2 inhibitors. Diabetes Care. 2015, 38:1638-1642. 10.2337\/dc15-1380","journal-title":"Diabetes Care"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-0843","article-title":"Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose cotransporter 2 inhibition","volume":"38","author":"Peters AL","year":"2015","unstructured":"Peters AL, Buschur EO, Buse JB, Cohan P, Diner JC, Hirsch IB. Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose cotransporter 2 inhibition. Diabetes Care. 2015, 38:1687-1693. 10.2337\/dc15-0843","journal-title":"Diabetes Care"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/40098-sodium-glucose-linked-transporter-inhibitors-as-a-cause-of-euglycemic-diabetic-ketoacidosis-on-a-background-of-starvation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:21:45Z","timestamp":1707506505000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/40098-sodium-glucose-linked-transporter-inhibitors-as-a-cause-of-euglycemic-diabetic-ketoacidosis-on-a-background-of-starvation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,27]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.10078","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8,27]]}}}